Works matching DE "VALGANCICLOVIR"

Results: 292

Monitoring human cytomegalovirus infection in pediatric hematopoietic stem cell transplant recipients: using an affordable in-house qPCR assay for management of HCMV infection under limited resources.

Published in:

Transplant International, 2015, v. 28, n. 5, p. 594, doi. 10.1111/tri.12545

By:

Khansarinejad, Behzad;
Soleimanjahi, Hoorieh;
Mirab Samiee, Siamak;
Hamidieh, Amir Ali;
Paryan, Mahdi;
Sanahmadi, Yadollah;
Karami, Manoochehr;
Mondanizadeh, Mahdieh

Publication type:

Article

(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation.

Published in:

Transplant International, 2012, v. 25, n. 7, p. 723, doi. 10.1111/j.1432-2277.2012.01485.x

By:

Höcker, Britta;
Böhm, Stephan;
Fickenscher, Helmut;
Küsters, Uta;
Schnitzler, Paul;
Pohl, Martin;
John, Ulrike;
Kemper, Markus J.;
Fehrenbach, Henry;
Wigger, Marianne;
Holder, Martin;
Schröder, Monika;
Feneberg, Reinhard;
Köpf-Shakib, Sabine;
Tönshoff, Burkhard

Publication type:

Article

Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients.

Published in:

Transplant International, 2011, v. 24, n. 9, p. 920, doi. 10.1111/j.1432-2277.2011.01285.x

By:

La Rosa, Corinna;
Limaye, Ajit P.;
Krishnan, Aparna;
Blumstein, Gideon;
Longmate, Jeff;
Diamond, Don J.

Publication type:

Article

Pre-emptive intravenous ganciclovir versus valganciclovir prophylaxis for de novo cytomegalovirus-seropositive kidney-transplant recipients.

Published in:

Transplant International, 2010, v. 23, n. 10, p. 1056, doi. 10.1111/j.1432-2277.2010.01101.x

By:

Weclawiak, Hugo;
Kamar, Nassim;
Mengelle, Catherine;
Esposito, Laure;
Mohamed, Abdellatif Ould;
Lavayssiere, Laurence;
Ribes, David;
Cointault, Olivier;
Nogier, Marie-Béatrice;
Cardeau-Desangles, Isabelle;
Izopet, Jacques;
Rostaing, Lionel

Publication type:

Article

Six months anti-viral prophylaxis significantly decreased cytomegalovirus disease compared with no anti-viral prophylaxis following renal transplantation.

Published in:

Transplant International, 2010, v. 23, n. 9, p. 897, doi. 10.1111/j.1432-2277.2010.01073.x

By:

Leone, Francesca;
Akl, Ahmed;
Giral, Magali;
Dantal, Jacques;
Blancho, Gilles;
Soulillou, Jean-Paul;
Cantarovich, Diego

Publication type:

Article

A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection.

Published in:

Transplant International, 2010, v. 23, n. 5, p. 506, doi. 10.1111/j.1432-2277.2009.01017.x

By:

Eid, Albert J.;
Brown, Robert A.;
Arthurs, Supha K.;
Lahr, Brian D.;
Eckel-Passow, Jeanette E.;
Larson, Timothy S.;
Razonable, Raymund R.

Publication type:

Article

Limited sampling strategy for the estimation of the area under the concentration-time curve for ganciclovir in Chinese adult renal allograft recipients.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 5, p. 677, doi. 10.1007/s00228-018-02613-w

By:

Rui, Wen-Bin;
An, Hui-Min;
Shao, Kun;
Zhai, Xiao-Hui;
Lu, Jia-Qian;
Hu, Shan-Shan;
Chen, Bing;
Zhou, Pei-Jun

Publication type:

Article

Valganciclovir—Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship.

Published in:

Antibiotics (2079-6382), 2021, v. 10, n. 1, p. 77, doi. 10.3390/antibiotics10010077

By:

Galar, Alicia;
Valerio, Maricela;
Catalán, Pilar;
García-González, Xandra;
Burillo, Almudena;
Fernández-Cruz, Ana;
Zataráin, Eduardo;
Sousa-Casasnovas, Iago;
Anaya, Fernando;
Rodríguez-Ferrero, María Luisa;
Muñoz, Patricia;
Bouza, Emilio

Publication type:

Article

Meet in the middle: Could cell mediated‐immunity assays be the answer for ideal Cytomegalovirus prophylaxis after lung transplantation? Observational study from a single center with intermittent antiviral prophylaxis.

Published in:

Transplant Infectious Disease, 2024, v. 26, n. 5, p. 1, doi. 10.1111/tid.14198

By:

Campos, Sílvia Vidal;
Teixeira, Lisete Ribeiro;
Freire, Maristela Pinheiro;
Mamana, Ana Carolina;
Machado, Clarisse Martins

Publication type:

Article

Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients.

Published in:

Transplant Infectious Disease, 2024, v. 26, n. 3, p. 1, doi. 10.1111/tid.14279

By:

Martinez, Sydni;
Sindu, Devika;
Nailor, Michael D.;
Cherrier, Lauren;
Tokman, Sofya;
Walia, Rajat;
Goodlet, Kellie J.

Publication type:

Article

Trough ganciclovir concentration as predictor of leukopenia in lung transplant recipients receiving valganciclovir prophylaxis.

Published in:

Transplant Infectious Disease, 2023, v. 25, n. 6, p. 1, doi. 10.1111/tid.14141

By:

Katada, Yoshiki;
Nakagawa, Shunsaku;
Nagao, Miki;
Umemura, Keisuke;
Itohara, Kotaro;
Nishikawa, Asami;
Hashi, Sachiyo;
Katsube, Yurie;
Hira, Daiki;
Ohsumi, Akihiro;
Nakajima, Daisuke;
Date, Hiroshi;
Terada, Tomohiro

Publication type:

Article

Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center.

Published in:

Transplant Infectious Disease, 2022, v. 24, n. 4, p. 1, doi. 10.1111/tid.13867

By:

Viehl, Emily;
Lichvar, Alicia;
Chan, Christine;
Choi, David

Publication type:

Article

Pharmacokinetics of valganciclovir and voriconazole during prolonged intermittent renal replacement therapy in a lung transplant recipient.

Published in:

Transplant Infectious Disease, 2022, v. 24, n. 2, p. 1, doi. 10.1111/tid.13818

By:

Whitmore, Timothy J;
Cheng, Vesa;
Rawlins, Matthew D;
Morgan, David;
Chang, Tim;
O'Halloran, Sean;
Dyer, John R;
Boan, Peter;
Roberts, Jason A

Publication type:

Article

Novel risk factor for valganciclovir toxicity—NUDT15 genetic variant.

Published in:

Transplant Infectious Disease, 2022, v. 24, n. 2, p. 1, doi. 10.1111/tid.13799

By:

Shingare, Ashay;
Dhope, Nikhil;
Bahadur, Madan M.

Publication type:

Article

Letermovir conversion after valganciclovir treatment in cytomegalovirus high‐risk abdominal solid organ transplant recipients may promote development of cytomegalovirus‐specific cell mediated immunity.

Published in:

Transplant Infectious Disease, 2022, v. 24, n. 1, p. 1, doi. 10.1111/tid.13766

By:

Jorgenson, Margaret R;
Kleiboeker, Hanna;
Garg, Neetika;
Parajuli, Sandesh;
Mandelbrot, Didier A;
Odorico, Jon S;
Saddler, Christopher M;
Smith, Jeannina A

Publication type:

Article

Comparison of standard versus low‐dose valganciclovir regimens for cytomegalovirus prophylaxis in high‐risk liver transplant recipients.

Published in:

Transplant Infectious Disease, 2021, v. 23, n. 5, p. 1, doi. 10.1111/tid.13713

By:

Bixby, Alexandra L.;
Fitzgerald, Linda;
Park, Jeong M.;
Kaul, Daniel;
Tischer, Sarah

Publication type:

Article

The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients.

Published in:

Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13693

By:

Jorgenson, Margaret R.;
Descourouez, Jillian L.;
Garg, Neetika;
Parajuli, Sandesh;
Mandelbrot, Didier A.;
Odorico, Jon S.;
Saddler, Christopher M.;
Smith, Jeannina A.

Publication type:

Article

Conversion from cytomegalovirus universal prophylaxis with valganciclovir to the preemptive monitoring approach to manage leukopenia after kidney or pancreas transplantation.

Published in:

Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13617

By:

Jorgenson, Margaret R.;
Wong, Cynthia;
Descourouez, Jillian L.;
Saddler, Christopher M.;
Smith, Jeannina A.;
Mandelbrot, Didier A.

Publication type:

Article

CMV infection, valganciclovir exposure, and the risk of BK viremia and associated nephropathy after kidney transplantation: Is there a link?

Published in:

Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13597

By:

Rodríguez‐Goncer, Isabel;
Ruiz‐Ruigómez, María;
López‐Medrano, Francisco;
Corbella, Laura;
Polanco, Natalia;
González Monte, Esther;
San Juan, Rafael;
Ruiz‐Merlo, Tamara;
Parra, Patricia;
Folgueira, Lola;
Andrés, Amado;
Aguado, José María;
Fernández‐Ruiz, Mario

Publication type:

Article

Examining valganciclovir prophylaxis duration among high‐risk donor seropositive/recipient seronegative heart transplant recipients in a larger cohort.

Published in:

Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13581

By:

Imlay, Hannah;
Dumitriu Carcoana, Allison O.;
Fisher, Cynthia E.;
Wong, Beatrice;
Rakita, Robert M.;
Fishbein, Daniel P.;
Limaye, Ajit P.

Publication type:

Article

The burden of cytomegalovirus infection remains high in high‐risk kidney transplant recipients despite six‐month valganciclovir prophylaxis.

Published in:

Transplant Infectious Disease, 2021, v. 23, n. 4, p. 1, doi. 10.1111/tid.13577

By:

Räihä, Juulia;
Ortiz, Fernanda;
Mannonen, Laura;
Loginov, Raisa;
Lempinen, Marko;
Lautenschlager, Irmeli;
Helanterä, Ilkka

Publication type:

Article

Trichodysplasia spinulosa: Case reports and review of literature.

Published in:

Transplant Infectious Disease, 2020, v. 22, n. 5, p. 1, doi. 10.1111/tid.13342

By:

Jose, Aju;
Dad, Taimur;
Strand, Andrew;
Tse, Julie Y.;
Plotnikova, Natalia;
Boucher, Helen W.;
Sarnak, Mark J.;
Gilbert, Scott J.;
Goyal, Nitender

Publication type:

Article

Evaluation of a change in cytomegalovirus prevention strategy following pediatric solid organ transplantation.

Published in:

Transplant Infectious Disease, 2020, v. 22, n. 2, p. 1, doi. 10.1111/tid.13232

By:

Pangonis, Scott;
Paulsen, Grant;
Andersen, Heidi;
Flores, Francisco;
Miethke, Alexander;
Peters, Anna;
Kocoshis, Samuel;
Lazear, Danielle;
Garr, BreAnn;
Schecter, Marc;
Chin, Clifford;
Hemmelgarn, Trina;
Danziger‐Isakov, Lara

Publication type:

Article

Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: Outcome and risk factors for late CMV disease.

Published in:

Transplant Infectious Disease, 2018, v. 20, n. 5, p. N.PAG, doi. 10.1111/tid.12929

By:

Reusing, Jose O.;
Feitosa, Emanoela B.;
Agena, Fabiana;
Pierrotti, Lígia C.;
Azevedo, Luiz S. F.;
David‐Neto, Elias;
Kotton, Camille N.

Publication type:

Article

Cytomegalovirus infection in heart transplantation: A single center experience.

Published in:

Transplant Infectious Disease, 2018, v. 20, n. 4, p. 1, doi. 10.1111/tid.12896

By:

Echenique, Ignacio A.;
Angarone, Michael P.;
Rich, Jonathan D.;
Anderson, Allen S.;
Stosor, Valentina

Publication type:

Article

Low‐dose valganciclovir prohylaxis is efficacious and safe in cytomegalovirus seropositive heart transplant recipients with anti‐thymocyte globulin.

Published in:

Transplant Infectious Disease, 2018, v. 20, n. 3, p. 1, doi. 10.1111/tid.12868

By:

Eriksson, Mari;
Lommi, Jyri;
Jokinen, Janne J.;
Hämmäinen, Pekka;
Lemström, Karl;
Söderlund, Sanni

Publication type:

Article

Impact of electronic health record‐based, pharmacist‐driven valganciclovir dose optimization in solid organ transplant recipients.

Published in:

Transplant Infectious Disease, 2018, v. 20, n. 2, p. 1, doi. 10.1111/tid.12849

By:

Hensler, David;
Richardson, Chad L.;
Brown, Joslyn;
Tseng, Christine;
DeCamp, Phyllis J.;
Yang, Amy;
Pawlowski, Anna;
Ho, Bing;
Ison, Michael G.

Publication type:

Article

Safety and efficacy of foscarnet for the management of ganciclovir‐resistant or refractory cytomegalovirus infections: A single‐center study.

Published in:

Transplant Infectious Disease, 2018, v. 20, n. 2, p. 1, doi. 10.1111/tid.12852

By:

Pierce, Brett;
Richardson, Chad L.;
Lacloche, Lisa;
Allen, Anne;
Ison, Michael G.

Publication type:

Article

Low-dose valganciclovir prophylaxis for cytomegalovirus in intermediate-risk (R+) renal transplant recipients: Single-center experience.

Published in:

Transplant Infectious Disease, 2017, v. 19, n. 6, p. n/a, doi. 10.1111/tid.12780

By:

Khan, Salman;
Fischman, Clara;
Huprikar, Shirish

Publication type:

Article

Valganciclovir ( VGCV) followed by cytomegalovirus ( CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot study.

Published in:

Transplant Infectious Disease, 2017, v. 19, n. 6, p. n/a, doi. 10.1111/tid.12779

By:

Fleming, James N.;
Taber, David J.;
Weimert, Nicole A.;
Nadig, Satish;
McGillicuddy, John W.;
Bratton, Charles F.;
Baliga, Prabhakar K.;
Chavin, Kenneth D.

Publication type:

Article

Leflunomide for the treatment of trichodysplasia spinulosa in a liver transplant recipient.

Published in:

Transplant Infectious Disease, 2017, v. 19, n. 4, p. n/a, doi. 10.1111/tid.12702

By:

Kassar, Rawan;
Chang, Janis;
Chan, An‐Wen;
Lilly, Leslie B.;
Al Habeeb, Ayman;
Rotstein, Coleman

Publication type:

Article

Fulminant Cytomegalovirus Myocarditis in an Immunocompetent Host: Resolution with Oral Valganciclovir.

Published in:

Texas Heart Institute Journal, 2014, v. 41, n. 5, p. 523, doi. 10.14503/THIJ-13-3504

By:

Padala, Santosh K.;
Kumar, Anupam;
Padala, Sandeep

Publication type:

Article

Oral valganciclovir versus intravenous ganciclovir as preemptive treatment for cytomegalovirus infection after living donor liver transplantation: A randomized trial.

Published in:

BioScience Trends, 2011, v. 5, n. 5, p. 217, doi. 10.5582/bst.2011.v5.5.217

By:

Togashi, Junichi;
Sugawara, Yasuhiko;
Hashimoto, Masao;
Tamura, Sumihito;
Kaneko, Junichi;
Aoki, Taku;
Hasegawa, Kiyoshi;
Kokudo, Norihiro

Publication type:

Article

Optimizing ganciclovir and valganciclovir dosing regimens in pediatric patients with cytomegalovirus infection: a spotlight on therapeutic drug monitoring.

Published in:

Expert Review of Clinical Pharmacology, 2023, v. 16, n. 8, p. 727, doi. 10.1080/17512433.2023.2181161

By:

Li, Qiu-Yue;
van den Anker, John;
Wu, Yue-E;
Hao, Guo-Xiang;
Zhao, Wei

Publication type:

Article

Congenital and Postnatal Cytomegalovirus: Case Series and State of the Science for Neonatal Providers.

Published in:

Neonatal Network, 2024, v. 43, n. 2, p. 92, doi. 10.1891/NN-2023-0069

By:

Salemi, Taylor F.;
McLean, Vanessa R.;
Jnah, Amy J.

Publication type:

Article

Congenital Cytomegalovirus—History, Current Practice, and Future Opportunities.

Published in:

Neonatal Network, 2020, v. 39, n. 5, p. 293, doi. 10.1891/0730-0832.39.5.293

By:

Thigpen, Jim

Publication type:

Article

Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection.

Published in:

International Journal of Molecular Sciences, 2019, v. 20, n. 6, p. 1388, doi. 10.3390/ijms20061388

By:

Ohyama, Shohei;
Fukushima, Sachiyo;
Yamana, Keiji;
Nishida, Kosuke;
Iwatani, Sota;
Fujioka, Kazumichi;
Iijima, Kazumoto;
Morioka, Ichiro;
Matsumoto, Hisayuki;
Imanishi, Takamitsu;
Nakamachi, Yuji;
Deguchi, Masashi;
Tanimura, Kenji;
Yamada, Hideto

Publication type:

Article

Emerging (val)ganciclovir resistance during treatment of congenital CMV infection: a case report and review of the literature.

Published in:

2017

By:

Morillo-Gutierrez, Beatriz;
Waugh, Sheila;
Pickering, Ailsa;
Flood, Terence;
Emonts, Marieke

Publication type:

journal article

A comparative study of valaciclovir, valganciclovir, and artesunate efficacy in reactivated HHV‐6 and HHV‐7 infections associated with chronic fatigue syndrome/myalgic encephalomyelitis.

Published in:: Microbiology & Immunology, 2022, v. 66, n. 4, p. 193, doi. 10.1111/1348-0421.12966
Publication type:: Article

Successful Treatment with Oral Valganciclovir of Primary CMV Enterocolitis in a Congenitally Infected Infant.

Published in:

Fetal & Pediatric Pathology, 2011, v. 30, n. 6, p. 437, doi. 10.3109/15513815.2011.587501

By:

Irizarry, Karina;
Honigbaum, Stefany;
Demmler-Harrison, Gail;
Rippel, Sara;
Wilsey, Michael

Publication type:

Article

Cytomegalovirus infection of a cutaneous ulcer in a patient with ANCA-positive vasculitis.

Published in:

2007

By:

Nolan, Richard C.;
Sadler, Genevieve M.;
Forrest, Cynthia H.;
Stacey, Michael C.;
Mallon, Dominic F.

Publication type:

Report

Severe Diffuse Ulcerative Esophagitis Caused by Epstein-Barr Virus/Cytomegalovirus Coinfection in an Immunocompetent Individual.

Published in:

ACG Case Reports Journal, 2025, v. 12, n. 1, p. 1, doi. 10.14309/crj.0000000000001578

By:

Mathur, Kartikeya;
Birda, Chhagan Lal;
Singh, Satyam Kumar;
Uppuv, Vvienodd;
Kashyap, Shubham;
Agarwal, Ashish

Publication type:

Article

Challenges in Managing Cytomegalovirus Colitis in a Complex Case of Ulcerative Colitis With Hyposplenism and Ustekinumab Therapy.

Published in:

ACG Case Reports Journal, 2024, v. 11, n. 10, p. 1, doi. 10.14309/crj.0000000000001536

By:

Hung, Natalie G.;
Malik, Sameer;
Cachia, Charlotte;
Ly, Theresa;
Leong, Rupert

Publication type:

Article

The Unmasking of Cytomegalovirus as an Accomplice to Helicobacter pylori-Induced Severe Acute Gastroenteritis in a Healthy Host.

Published in:

ACG Case Reports Journal, 2023, v. 10, n. 10, p. 1, doi. 10.14309/crj.0000000000001181

By:

Kreidieh, Malek;
Gurala, Dhineshreddy;
Amarnath, Shivantha;
Philipose, Jobin;
Colef, Robert;
Yassine, Ahmad Abou;
Gumaste, Vivek

Publication type:

Article

Cytomegalovirus infection - cause of sensorineural deafness.

Published in:

2016

By:

Anton-Păduraru, Dana-Teodora;
Teslariu, Oana;
Marin, Angelica-Cristina;
Drochioi, Ana-Simona

Publication type:

Abstract

Valganciclovir and Risk for Neutropenia: When the Friend Becomes the Foe.

Published in:

Pediatric Transplantation, 2024, v. 28, n. 5, p. 1, doi. 10.1111/petr.14817

By:

Nalli, Nadya;
Teoh, Chia Wei;
Allen, Upton

Publication type:

Article

Comment on "Evaluation of valganciclovir's neutropenia risk in pediatric solid organ transplant recipients utilizing two dosing regimens".

Published in:

Pediatric Transplantation, 2024, v. 28, n. 3, p. 1, doi. 10.1111/petr.14754

By:

Daungsupawong, Hinpetch;
Wiwanitkit, Viroj

Publication type:

Article

Evaluation of valganciclovir's neutropenia risk in pediatric solid organ transplant recipients utilizing two dosing regimens.

Published in:

Pediatric Transplantation, 2024, v. 28, n. 2, p. 1, doi. 10.1111/petr.14714

By:

Patel, Avani;
Le, Kevin;
Panek, Natalia

Publication type:

Article

"Weight‐ing" for an answer on optimal valganciclovir prophylaxis dosing in pediatric solid organ transplantation recipients.

Published in:

Pediatric Transplantation, 2023, v. 27, n. 4, p. 1, doi. 10.1111/petr.14494

By:

Dulek, D. E.;
Ardura, M. I.

Publication type:

Article

Incidence of cytomegalovirus DNAemia in pediatric kidney, liver, and heart transplant recipients: Efficacy and risk factors associated with failure of weight‐based dosed valganciclovir prophylaxis.

Published in:

Pediatric Transplantation, 2023, v. 27, n. 4, p. 1, doi. 10.1111/petr.14493

By:

Liverman, Rochelle;
Serluco, Anastacia;
Nance, Gwen;
George, Roshan;
Rodriguez, Dellys Soler;
Deshpande, Shriprasad;
Mao, Chad;
Garro, Rouba;
Yildirim, Inci

Publication type:

Article